The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma

12 of 47 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Carcinoma, Squamous Cell; Skin Neoplasms; Neoplasm Recurrence, Local; Disease-Free Survival; Chemotherapy, Adjuvant; Double-Blind Method; Adult; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
40454639
Added to directory
Source checked

Report a correction or request removal